Aurobindo Pharma (AUROPHARMA) — Announcement

📢 Key Event
Aurobindo Pharma to attend Motilal Oswal investor conference

💡 Investor Takeaway
This filing does not disclose new financial data or strategic updates, so it carries no direct impact on valuation or investment decisions.

Aurobindo Pharma announced its participation in the Motilal Oswal Annual Global Investor Conference on August 19, 2026, in Mumbai, offering one-on-one and group meetings with company officials. The filing confirms the event details and location but contains no financial results, guidance updates, or new risks, making it a routine corporate communication without immediate investment implications.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Limited (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹96,836.1 Cr P/E: 26.3 ROE: 9.8% ROCE: 12.8% Div Yield: 0.24%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"What is the expected attendance count?" "Will any guidance be shared?" "How does this compare to peer conference participation?"

Ask AI Free →

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

🔥 Also filed on 14 August 2026

CEIGALL Ceigall India Limited Financial Results MAHAPEXLTD Maha Rashtra Apex Corporation Limited Corporate Action SAATVIKGL Saatvik Green Energy Limited Financial Results LIBAS Libas Consumer Products Limited Corporate Action GENUSPOWER Genus Power Infrastructures Limited Financial Results LUXIND Lux Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AUROPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd